Nancy S Shulman

Genetic correlates of efavirenz hypersusceptibility

Ronald J Bosch, D. Katzenstein, J. Mellors, 2004, AIDS.

Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection.

Steven C Johnson, Steven C. Johnson, Daniel R Kuritzkes, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

Tom Chu, Peter W Angus, P. Angus, 2010, The Lancet.

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors: A Clinical Review of Antiretroviral Resistance

Joel E Gallant, R. Haubrich, D. Richman, 2002, Antiviral therapy.

Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients.

Aijaz Ahmed, Tommy F. Liu, Tommy Liu, 2009, The Journal of infectious diseases.